| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | ANO4 CLCN1 SLC38A9 AQP11 SLC28A2 ABCC5 PKD2L1 XKR8 SERINC3 ANO7 CTNS ATP1A4 PKDREJ SLC1A1 RYR2 SLC44A3 | 4.97e-06 | 1289 | 68 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ANO4 CLCN1 SLC38A9 AQP11 SLC28A2 ABCC5 PKD2L1 SERINC3 ANO7 CTNS ATP1A4 PKDREJ SLC1A1 RYR2 SLC44A3 | 7.86e-06 | 1180 | 68 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ANO4 CLCN1 AQP11 SLC28A2 ABCC5 PKD2L1 ANO7 CTNS ATP1A4 PKDREJ SLC1A1 RYR2 | 8.47e-06 | 758 | 68 | 12 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | CCR2 CELSR1 GPR158 OR10J3 TLR3 PKD2L1 GPRC5D KIR2DL1 TAS2R20 OR56A1 PTGER2 F3 OR56B4 AGTRAP OR2W6P | 3.94e-05 | 1353 | 68 | 15 | GO:0004888 |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 6.37e-05 | 23 | 68 | 3 | GO:0017128 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.01e-04 | 71 | 68 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | CCR2 CELSR1 GPR158 OR10J3 GPRC5D TAS2R20 OR56A1 PTGER2 OR56B4 AGTRAP OR2W6P | 1.83e-04 | 884 | 68 | 11 | GO:0004930 |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 1.85e-04 | 83 | 68 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.93e-04 | 171 | 68 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | nodal binding | 3.16e-04 | 8 | 68 | 2 | GO:0038100 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANO4 CLCN1 SLC28A2 PKD2L1 ANO7 CTNS ATP1A4 PKDREJ SLC1A1 RYR2 | 3.33e-04 | 793 | 68 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | channel activity | 4.01e-04 | 525 | 68 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 4.06e-04 | 526 | 68 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 4.22e-04 | 103 | 68 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 4.54e-04 | 105 | 68 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 6.16e-04 | 11 | 68 | 2 | GO:0000099 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 7.00e-04 | 51 | 68 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 8.75e-04 | 125 | 68 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 9.38e-04 | 459 | 68 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | activin receptor binding | 1.01e-03 | 14 | 68 | 2 | GO:0070697 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.18e-03 | 61 | 68 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.76e-03 | 151 | 68 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 2.06e-03 | 74 | 68 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 2.09e-03 | 20 | 68 | 2 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 2.09e-03 | 20 | 68 | 2 | GO:0005229 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.76e-03 | 171 | 68 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | chloride channel activity | 3.16e-03 | 86 | 68 | 3 | GO:0005254 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.22e-03 | 293 | 68 | 5 | GO:0008514 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase binding | 3.80e-03 | 27 | 68 | 2 | GO:0070696 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.25e-03 | 193 | 68 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.58e-03 | 197 | 68 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 5.00e-03 | 465 | 68 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 5.38e-03 | 627 | 68 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 5.45e-03 | 207 | 68 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 5.54e-03 | 208 | 68 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | gated channel activity | 5.60e-03 | 334 | 68 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 5.64e-03 | 33 | 68 | 2 | GO:0072349 | |
| GeneOntologyMolecularFunction | taste receptor activity | 5.64e-03 | 33 | 68 | 2 | GO:0008527 | |
| GeneOntologyMolecularFunction | receptor serine/threonine kinase binding | 6.32e-03 | 35 | 68 | 2 | GO:0033612 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 7.30e-03 | 664 | 68 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 7.81e-03 | 119 | 68 | 3 | GO:0015294 | |
| GeneOntologyBiologicalProcess | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis | 1.10e-05 | 2 | 69 | 2 | GO:0060488 | |
| GeneOntologyBiologicalProcess | planar dichotomous subdivision of terminal units involved in lung branching morphogenesis | 1.10e-05 | 2 | 69 | 2 | GO:0060489 | |
| GeneOntologyBiologicalProcess | lateral sprouting involved in lung morphogenesis | 1.10e-05 | 2 | 69 | 2 | GO:0060490 | |
| GeneOntologyBiologicalProcess | dichotomous subdivision of terminal units involved in lung branching | 3.30e-05 | 3 | 69 | 2 | GO:0060448 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 4.86e-05 | 60 | 69 | 4 | GO:0015804 | |
| GeneOntologyBiologicalProcess | calcium activated phosphatidylserine scrambling | 6.59e-05 | 4 | 69 | 2 | GO:0061589 | |
| GeneOntologyBiologicalProcess | establishment of body hair planar orientation | 6.59e-05 | 4 | 69 | 2 | GO:0048105 | |
| GeneOntologyBiologicalProcess | establishment of body hair or bristle planar orientation | 6.59e-05 | 4 | 69 | 2 | GO:0048104 | |
| GeneOntologyBiologicalProcess | left lung morphogenesis | 6.59e-05 | 4 | 69 | 2 | GO:0060460 | |
| GeneOntologyBiologicalProcess | plasma membrane phospholipid scrambling | 8.82e-05 | 26 | 69 | 3 | GO:0017121 | |
| GeneOntologyBiologicalProcess | calcium activated phospholipid scrambling | 1.10e-04 | 5 | 69 | 2 | GO:0061588 | |
| GeneOntologyBiologicalProcess | calcium activated phosphatidylcholine scrambling | 1.10e-04 | 5 | 69 | 2 | GO:0061590 | |
| GeneOntologyBiologicalProcess | calcium activated galactosylceramide scrambling | 1.10e-04 | 5 | 69 | 2 | GO:0061591 | |
| GeneOntologyBiologicalProcess | left lung development | 1.10e-04 | 5 | 69 | 2 | GO:0060459 | |
| GeneOntologyBiologicalProcess | lung morphogenesis | 1.29e-04 | 77 | 69 | 4 | GO:0060425 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 1.50e-04 | 80 | 69 | 4 | GO:0003143 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.61e-04 | 153 | 69 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | neutrophil clearance | 1.64e-04 | 6 | 69 | 2 | GO:0097350 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | CCR2 PDE3A CELSR1 GPR158 OR10J3 ENTPD1 GPRC5D TAS2R20 OR56A1 PTGER2 SLC1A1 OR56B4 AGTRAP OR2W6P | 1.80e-04 | 1395 | 69 | 14 | GO:0007186 |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 2.07e-04 | 87 | 69 | 4 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 2.16e-04 | 88 | 69 | 4 | GO:0010232 | |
| GeneOntologyBiologicalProcess | detection of virus | 2.29e-04 | 7 | 69 | 2 | GO:0009597 | |
| GeneOntologyBiologicalProcess | response to wounding | 3.36e-04 | 659 | 69 | 9 | GO:0009611 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.69e-04 | 183 | 69 | 5 | GO:0006820 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 3.75e-04 | 284 | 69 | 6 | GO:0007626 | |
| GeneOntologyBiologicalProcess | embryonic heart tube development | 3.95e-04 | 103 | 69 | 4 | GO:0035050 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 4.73e-04 | 108 | 69 | 4 | GO:0015807 | |
| GeneOntologyBiologicalProcess | proximal tubule development | 4.88e-04 | 10 | 69 | 2 | GO:0072014 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 5.43e-04 | 112 | 69 | 4 | GO:1902476 | |
| GeneOntologyBiologicalProcess | dichotomous subdivision of an epithelial terminal unit | 5.95e-04 | 11 | 69 | 2 | GO:0060600 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR10J3 PKD2L1 TMEM107 TAS2R20 OR56A1 PKDREJ OR56B4 RYR2 OR2W6P | 6.51e-04 | 722 | 69 | 9 | GO:0051606 |
| GeneOntologyBiologicalProcess | action potential propagation | 7.12e-04 | 12 | 69 | 2 | GO:0098870 | |
| GeneOntologyBiologicalProcess | neuronal action potential propagation | 7.12e-04 | 12 | 69 | 2 | GO:0019227 | |
| GeneOntologyBiologicalProcess | positive regulation of blood circulation | 7.45e-04 | 53 | 69 | 3 | GO:1903524 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 8.30e-04 | 55 | 69 | 3 | GO:0045332 | |
| GeneOntologyBiologicalProcess | sulfur amino acid transport | 8.40e-04 | 13 | 69 | 2 | GO:0000101 | |
| GeneOntologyBiologicalProcess | lateral sprouting from an epithelium | 8.40e-04 | 13 | 69 | 2 | GO:0060601 | |
| GeneOntologyBiologicalProcess | chloride transport | 8.96e-04 | 128 | 69 | 4 | GO:0006821 | |
| GeneOntologyCellularComponent | vesicle membrane | ARFGEF3 VPS18 TMEM45B SLC38A9 AQP11 TLR3 SLC28A2 ABCC5 ULK1 CTNS DCST2 KIR2DL1 SLC1A1 AGTRAP | 9.08e-05 | 1325 | 69 | 14 | GO:0012506 |
| GeneOntologyCellularComponent | cell surface | PMP22 CCR2 AQP11 ENTPD1 CLPTM1 TLR3 CFC1 PKD2L1 DUOX2 CFC1B F3 SLC1A1 | 2.54e-04 | 1111 | 69 | 12 | GO:0009986 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ARFGEF3 VPS18 TMEM45B SLC38A9 AQP11 TLR3 ABCC5 ULK1 CTNS DCST2 KIR2DL1 SLC1A1 AGTRAP | 3.04e-04 | 1307 | 69 | 13 | GO:0030659 |
| MousePheno | total anomalous pulmonary venous connection, intracardiac | 1.41e-05 | 2 | 53 | 2 | MP:0010443 | |
| MousePheno | impaired leukocyte tethering or rolling | 5.61e-05 | 20 | 53 | 3 | MP:0020332 | |
| MousePheno | dilated terminal bronchiole tube | 8.42e-05 | 4 | 53 | 2 | MP:0006026 | |
| MousePheno | unbalanced complete common atrioventricular canal | 8.42e-05 | 4 | 53 | 2 | MP:0011673 | |
| MousePheno | total anomalous pulmonary venous connection | 8.42e-05 | 4 | 53 | 2 | MP:0010441 | |
| MousePheno | impaired branching involved in terminal bronchiole morphogenesis | 1.40e-04 | 5 | 53 | 2 | MP:0011032 | |
| MousePheno | female infertility | 1.43e-04 | 410 | 53 | 8 | MP:0001926 | |
| MousePheno | abnormal leukocyte tethering or rolling | 2.59e-04 | 33 | 53 | 3 | MP:0003627 | |
| MousePheno | small lung lobe | 2.93e-04 | 7 | 53 | 2 | MP:0010976 | |
| MousePheno | abnormal branching involved in terminal bronchiole morphogenesis | 2.93e-04 | 7 | 53 | 2 | MP:0011031 | |
| MousePheno | superior-inferior ventricles | 2.93e-04 | 7 | 53 | 2 | MP:0011254 | |
| MousePheno | vascular ring | 3.09e-04 | 35 | 53 | 3 | MP:0010466 | |
| Domain | CFC | 3.79e-05 | 3 | 67 | 2 | PF09443 | |
| Domain | DUF716_TMEM45 | 3.79e-05 | 3 | 67 | 2 | IPR006904 | |
| Domain | Cryptic/Cripto_CFC-dom | 3.79e-05 | 3 | 67 | 2 | IPR019011 | |
| Domain | DUF716 | 3.79e-05 | 3 | 67 | 2 | PF04819 | |
| Domain | TM_Fragile-X-F-assoc | 7.57e-05 | 4 | 67 | 2 | IPR019396 | |
| Domain | Tmemb_185A | 7.57e-05 | 4 | 67 | 2 | PF10269 | |
| Domain | PKD_2 | 1.26e-04 | 5 | 67 | 2 | IPR003915 | |
| Domain | TDE1/TMS | 1.26e-04 | 5 | 67 | 2 | IPR005016 | |
| Domain | Serinc | 1.26e-04 | 5 | 67 | 2 | PF03348 | |
| Domain | Anoct_dimer | 2.63e-04 | 7 | 67 | 2 | PF16178 | |
| Domain | Anoct_dimer | 2.63e-04 | 7 | 67 | 2 | IPR032394 | |
| Domain | Phosphodiest | 5.60e-04 | 10 | 67 | 2 | PF01663 | |
| Domain | Anoctamin | 5.60e-04 | 10 | 67 | 2 | PF04547 | |
| Domain | Anoctamin | 5.60e-04 | 10 | 67 | 2 | IPR007632 | |
| Domain | Phosphodiest/P_Trfase | 5.60e-04 | 10 | 67 | 2 | IPR002591 | |
| Domain | PKD_channel | 6.83e-04 | 11 | 67 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 6.83e-04 | 11 | 67 | 2 | IPR013122 | |
| Domain | Aa_trans | 1.67e-03 | 17 | 67 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 1.67e-03 | 17 | 67 | 2 | IPR013057 | |
| Domain | GPCR_3 | 2.55e-03 | 21 | 67 | 2 | IPR000337 | |
| Domain | 7tm_3 | 2.80e-03 | 22 | 67 | 2 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 2.80e-03 | 22 | 67 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 2.80e-03 | 22 | 67 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 2.80e-03 | 22 | 67 | 2 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 2.80e-03 | 22 | 67 | 2 | PS50259 | |
| Domain | GPCR_3_C | 2.80e-03 | 22 | 67 | 2 | IPR017978 | |
| Domain | Alkaline_phosphatase_core | 5.51e-03 | 31 | 67 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 5.51e-03 | 31 | 67 | 2 | IPR017849 | |
| Domain | - | 5.51e-03 | 31 | 67 | 2 | 3.40.720.10 | |
| Domain | GPS | 6.60e-03 | 34 | 67 | 2 | SM00303 | |
| Domain | GPS | 7.79e-03 | 37 | 67 | 2 | IPR000203 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ANO4 CLCN1 AQP11 SLC28A2 ABCC5 ANO7 CTNS ATP1A4 SLC1A1 RYR2 SLC44A3 | 8.74e-06 | 681 | 46 | 11 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ANO4 CLCN1 AQP11 SLC28A2 ABCC5 ANO7 CTNS ATP1A4 SLC1A1 RYR2 SLC44A3 | 1.81e-05 | 736 | 46 | 11 | M27287 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.60e-04 | 176 | 46 | 5 | MM15718 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 2.98e-04 | 99 | 46 | 4 | MM14910 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.11e-04 | 183 | 46 | 5 | M997 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 3.70e-04 | 9 | 46 | 2 | M27959 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 3.70e-04 | 9 | 46 | 2 | MM15707 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 3.87e-04 | 106 | 46 | 4 | M27200 | |
| Pathway | WP_MIR127_IN_MESENDODERM_DIFFERENTIATION | 6.73e-04 | 12 | 46 | 2 | MM15910 | |
| Pathway | REACTOME_INDUCTION_OF_CELL_CELL_FUSION | 7.94e-04 | 13 | 46 | 2 | M46426 | |
| Pubmed | A genome-wide association search for type 2 diabetes genes in African Americans. | 2.60e-07 | 7 | 69 | 3 | 22238593 | |
| Pubmed | 2.21e-06 | 430 | 69 | 8 | 16303743 | ||
| Pubmed | Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells. | 3.34e-06 | 15 | 69 | 3 | 17360443 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 12404111 | ||
| Pubmed | The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. | 3.88e-06 | 2 | 69 | 2 | 11174844 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 31519864 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 11327798 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 11024280 | ||
| Pubmed | Celsr1 is required for the generation of polarity at multiple levels of the mouse oviduct. | 3.88e-06 | 2 | 69 | 2 | 25406397 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 11062482 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 33293358 | ||
| Pubmed | Conserved regulation and role of Pitx2 in situs-specific morphogenesis of visceral organs. | 1.16e-05 | 3 | 69 | 2 | 16835440 | |
| Pubmed | Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2). | 1.16e-05 | 3 | 69 | 2 | 10602361 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 15879158 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 19549382 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 20056126 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 16571411 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 11825688 | ||
| Pubmed | Celsr1 adhesive interactions mediate the asymmetric organization of planar polarity complexes. | 2.32e-05 | 4 | 69 | 2 | 33529151 | |
| Pubmed | [Analysis of HLA-Cw, KIR2D genetic variations in 2 Chinese populations]. | 2.32e-05 | 4 | 69 | 2 | 18543232 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 21148036 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 25037176 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 18269867 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 29463853 | ||
| Pubmed | Specific arrest of cardiogenesis in cultured embryonic stem cells lacking Cripto-1. | 2.32e-05 | 4 | 69 | 2 | 9576836 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 20410850 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 26542066 | ||
| Pubmed | The physical and genetic map surrounding the Lyst gene on mouse chromosome 13. | 2.32e-05 | 4 | 69 | 2 | 9070932 | |
| Pubmed | Role of the EGF-CFC gene cripto in cell differentiation and embryo development. | 2.32e-05 | 4 | 69 | 2 | 11992720 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 16687519 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 11698076 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 16112031 | ||
| Pubmed | New mouse models for high resolution and live imaging of planar cell polarity proteins in vivo. | 3.86e-05 | 5 | 69 | 2 | 34463728 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 9053319 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 12121272 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 18755860 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 18322206 | ||
| Pubmed | Self-regulated left-right asymmetric expression of Pitx2c in the developing mouse limb. | 3.86e-05 | 5 | 69 | 2 | 25224222 | |
| Pubmed | Genetic interactions between planar cell polarity genes cause diverse neural tube defects in mice. | 3.86e-05 | 5 | 69 | 2 | 25128525 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 23996638 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 15525354 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 24752295 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 28599846 | ||
| Pubmed | Celsr1 and Celsr2 exhibit distinct adhesive interactions and contributions to planar cell polarity. | 5.79e-05 | 6 | 69 | 2 | 36712970 | |
| Pubmed | Gatm, a creatine synthesis enzyme, is imprinted in mouse placenta. | 5.79e-05 | 6 | 69 | 2 | 12671064 | |
| Pubmed | A role of the cryptic gene in the correct establishment of the left-right axis. | 5.79e-05 | 6 | 69 | 2 | 10574770 | |
| Pubmed | Celsr1 coordinates the planar polarity of vestibular hair cells during inner ear development. | 5.79e-05 | 6 | 69 | 2 | 28159525 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 27612405 | ||
| Pubmed | Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway. | 5.79e-05 | 6 | 69 | 2 | 12052855 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 17991893 | ||
| Pubmed | Epidermal wound repair is regulated by the planar cell polarity signaling pathway. | 5.79e-05 | 6 | 69 | 2 | 20643356 | |
| Pubmed | 5.83e-05 | 105 | 69 | 4 | 30280653 | ||
| Pubmed | Mitotic internalization of planar cell polarity proteins preserves tissue polarity. | 8.09e-05 | 7 | 69 | 2 | 21743464 | |
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 14607943 | ||
| Pubmed | Conserved requirement for EGF-CFC genes in vertebrate left-right axis formation. | 8.09e-05 | 7 | 69 | 2 | 10521397 | |
| Pubmed | Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors. | 8.09e-05 | 7 | 69 | 2 | 11169255 | |
| Pubmed | Reversal of left-right asymmetry induced by aberrant Nodal signaling in the node of mouse embryos. | 8.09e-05 | 7 | 69 | 2 | 19906859 | |
| Pubmed | ANOs 3-7 in the anoctamin/Tmem16 Cl- channel family are intracellular proteins. | 8.09e-05 | 7 | 69 | 2 | 22075693 | |
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 3402356 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 20935224 | ||
| Pubmed | Requirement for core 2 O-glycans for optimal resistance to helminth infection. | 1.08e-04 | 8 | 69 | 2 | 23555902 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 21419113 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 15730517 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 22946059 | ||
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 18681957 | ||
| Pubmed | Two nodal-responsive enhancers control left-right asymmetric expression of Nodal. | 1.08e-04 | 8 | 69 | 2 | 15736223 | |
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 7749980 | ||
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 31462532 | ||
| Pubmed | Left-right patterning of the mouse lateral plate requires nodal produced in the node. | 1.38e-04 | 9 | 69 | 2 | 12654299 | |
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 18773496 | ||
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 20704721 | ||
| Pubmed | 1.54e-04 | 52 | 69 | 3 | 26590417 | ||
| Pubmed | Comparative mapping in the beige-satin region of mouse chromosome 13. | 1.73e-04 | 10 | 69 | 2 | 9027500 | |
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 23610400 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 16805797 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 17913787 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 29510119 | ||
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 12559621 | ||
| Pubmed | Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels. | 1.73e-04 | 10 | 69 | 2 | 19015192 | |
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 30283008 | ||
| Pubmed | Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. | 1.73e-04 | 10 | 69 | 2 | 23532839 | |
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 24692353 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | 1.96e-04 | 1031 | 69 | 9 | 16710414 | |
| Pubmed | Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. | 2.11e-04 | 11 | 69 | 2 | 15475956 | |
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 18830515 | ||
| Pubmed | A dual role for planar cell polarity genes in ciliated cells. | 2.11e-04 | 11 | 69 | 2 | 25024228 | |
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 34274973 | ||
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 19693089 | ||
| Pubmed | Mouse model of muscleblind-like 1 overexpression: skeletal muscle effects and therapeutic promise. | 2.11e-04 | 11 | 69 | 2 | 22846424 | |
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 2.11e-04 | 11 | 69 | 2 | 19664392 | |
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 20371502 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 2.53e-04 | 12 | 69 | 2 | 19181658 | |
| Pubmed | Cofilin and Vangl2 cooperate in the initiation of planar cell polarity in the mouse embryo. | 2.53e-04 | 12 | 69 | 2 | 23406901 | |
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 19936734 | ||
| Pubmed | Microtubules enable the planar cell polarity of airway cilia. | 2.53e-04 | 12 | 69 | 2 | 23122850 | |
| Pubmed | Syndecan 4 controls lymphatic vasculature remodeling during mouse embryonic development. | 2.98e-04 | 13 | 69 | 2 | 27789626 | |
| Pubmed | 2.98e-04 | 13 | 69 | 2 | 18849982 | ||
| Pubmed | Convergent extension, planar-cell-polarity signalling and initiation of mouse neural tube closure. | 2.98e-04 | 13 | 69 | 2 | 17229766 | |
| Pubmed | 2.98e-04 | 13 | 69 | 2 | 18550712 | ||
| Pubmed | 2.98e-04 | 13 | 69 | 2 | 18687225 | ||
| Cytoband | 15q15.3 | 6.53e-04 | 25 | 69 | 2 | 15q15.3 | |
| Cytoband | 6q25.3 | 1.14e-03 | 33 | 69 | 2 | 6q25.3 | |
| Cytoband | 10q24 | 1.28e-03 | 35 | 69 | 2 | 10q24 | |
| Cytoband | 1q23.2 | 1.28e-03 | 35 | 69 | 2 | 1q23.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 1.44e-03 | 147 | 69 | 3 | chr15q15 | |
| Cytoband | 2q21.1 | 3.49e-03 | 58 | 69 | 2 | 2q21.1 | |
| GeneFamily | G protein-coupled receptors, Class C orphans | 1.15e-04 | 7 | 43 | 2 | 285 | |
| GeneFamily | Olfactory receptors, family 56 | 1.97e-04 | 9 | 43 | 2 | 167 | |
| GeneFamily | Anoctamins | 2.46e-04 | 10 | 43 | 2 | 865 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.18e-04 | 394 | 43 | 6 | 471 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 8.25e-04 | 18 | 43 | 2 | 620 | |
| GeneFamily | Solute carriers | 1.42e-02 | 395 | 43 | 4 | 752 | |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 2.95e-05 | 300 | 63 | 7 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#2_top-relative-expression-ranked_500 | 4.06e-05 | 129 | 63 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.56e-05 | 218 | 63 | 6 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k3 | |
| ToppCell | 11.5-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 7.10e-06 | 172 | 69 | 5 | 9d4d92e2d16dfc8a394f2641653bb97de20a2530 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.85e-06 | 180 | 69 | 5 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 190 | 69 | 5 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 190 | 69 | 5 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 190 | 69 | 5 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.18e-05 | 191 | 69 | 5 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-05 | 191 | 69 | 5 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 192 | 69 | 5 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 192 | 69 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.24e-05 | 193 | 69 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-05 | 194 | 69 | 5 | 0cd4363627acd419e00d6d32f6dce10430aa6487 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-05 | 194 | 69 | 5 | a58841b34efe673671a9a059238e044a7254b279 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 198 | 69 | 5 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 198 | 69 | 5 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | distal-1-Epithelial-Club|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.44e-05 | 199 | 69 | 5 | 8f0a72a95d0310ef2324c6975495c294b5a47cc8 | |
| ToppCell | distal-Epithelial-Club-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.44e-05 | 199 | 69 | 5 | 685cefbe6ff5db8b578e50b5849524ac2f347d0c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 200 | 69 | 5 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 200 | 69 | 5 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 200 | 69 | 5 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 200 | 69 | 5 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.47e-05 | 200 | 69 | 5 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.14e-05 | 124 | 69 | 4 | d88bce8a4f023d5b617b2e8e372a94bd1248d20d | |
| ToppCell | facs-Thymus-Epithelium-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 125 | 69 | 4 | 6bdbbd47b699d836900bd055f2144cf960b5e7b6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.10e-05 | 137 | 69 | 4 | 5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 152 | 69 | 4 | bd1f36b436d8ab7dd8420f595b97d851eab31a38 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 152 | 69 | 4 | ee329249a034a969a16b26a224aa04249d67382d | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.36e-05 | 153 | 69 | 4 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.03e-04 | 157 | 69 | 4 | 5fb41af247465aa29aa7b8edd26e3d3794766f80 | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.09e-04 | 159 | 69 | 4 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | 10x5'-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 1.09e-04 | 159 | 69 | 4 | c3d3570e83c5d25cc92fa3a7a8f0dc2f89a72913 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-CD163+_Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.11e-04 | 160 | 69 | 4 | 4480a7d6bd48d06b4e5196faac868f31ab7ed3ad | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 1.14e-04 | 161 | 69 | 4 | 15ba7e69699558353cfeecdcf1dbc2e147379ed6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-04 | 162 | 69 | 4 | 9f568836199a05f696294caac1ea3fa413984423 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.22e-04 | 164 | 69 | 4 | 3a4ecc632be003d09b765c992804134348d2278b | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.22e-04 | 164 | 69 | 4 | 4b10b78d4d76023c3c5bcd427757218fdd5465ca | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-04 | 166 | 69 | 4 | 3b67064a5149e72f895344d938c64b8ff65247f5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-04 | 170 | 69 | 4 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 170 | 69 | 4 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 170 | 69 | 4 | ff68600b945b3a5437b14e5411b3db800d0ccbe5 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.60e-04 | 176 | 69 | 4 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.68e-04 | 178 | 69 | 4 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 179 | 69 | 4 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | ASK440-Immune-NK_cell|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.75e-04 | 180 | 69 | 4 | 340e750356d23fe9af0e8f298f8a273ff426052f | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.75e-04 | 180 | 69 | 4 | 255097d8eb244a32eb2ecd0e7e48e1a20bafb5cd | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.82e-04 | 182 | 69 | 4 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.82e-04 | 182 | 69 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.86e-04 | 183 | 69 | 4 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.86e-04 | 183 | 69 | 4 | bd78e5c2670e67b4363078e3ca5a5b7081d24b7e | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.86e-04 | 183 | 69 | 4 | d1bf3abf42eb9d7facf775becf1338d1faadd647 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.90e-04 | 184 | 69 | 4 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.94e-04 | 185 | 69 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-04 | 185 | 69 | 4 | dc59b8dc459a3c444c9634a0d438cbef54c40036 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.98e-04 | 186 | 69 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.06e-04 | 188 | 69 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.06e-04 | 188 | 69 | 4 | 9fc3819aae5a2b2534cb131d467435b5cfc420d6 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 188 | 69 | 4 | 59b71462338a7efbacf46577cb07e9db3363afee | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.06e-04 | 188 | 69 | 4 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 189 | 69 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 189 | 69 | 4 | fac5c291a9a87418bb0878c3d624829bdbf1f428 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 189 | 69 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 2.15e-04 | 190 | 69 | 4 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | facs-Large_Intestine-Distal|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 190 | 69 | 4 | 3964a8390522b61b73235151bb0a2ff36b856867 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 2.15e-04 | 190 | 69 | 4 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-04 | 191 | 69 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 191 | 69 | 4 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-04 | 191 | 69 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-04 | 191 | 69 | 4 | ce76b156b153a2c7c9f2fb8e563b69c81073fbe5 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-04 | 191 | 69 | 4 | c006f5a6e3a32b79ac99a78304bdd5116fc0d5e0 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-04 | 191 | 69 | 4 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 191 | 69 | 4 | b842647caf05d39f602de83c647d5c224715d19f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-04 | 191 | 69 | 4 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 191 | 69 | 4 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.19e-04 | 191 | 69 | 4 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 192 | 69 | 4 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 192 | 69 | 4 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 192 | 69 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 192 | 69 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 192 | 69 | 4 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 192 | 69 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.28e-04 | 193 | 69 | 4 | e1855cff9a6bcfda9188b9fdf6c9d698405da990 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.28e-04 | 193 | 69 | 4 | aa10924b203c71e65fdbd2b90ba131dbd362d8b1 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | 4aee372ba2c0351b0221d0d468707d1ad21526d6 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | severe-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.28e-04 | 193 | 69 | 4 | f4d43dfbf4115dd0f843ea5cf08049220342a047 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Megakaryocyte|World / Lineage, cell class and subclass | 2.28e-04 | 193 | 69 | 4 | 352cd442b6e62f09b6d22a139774067873644594 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | aaa5042388dc451bff384c6bb237348f08280a08 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.28e-04 | 193 | 69 | 4 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.28e-04 | 193 | 69 | 4 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.33e-04 | 194 | 69 | 4 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 2.33e-04 | 194 | 69 | 4 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.37e-04 | 195 | 69 | 4 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 195 | 69 | 4 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.37e-04 | 195 | 69 | 4 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Neuronal-GABAergic_neurons|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-04 | 197 | 69 | 4 | e1a80c1aa7f7e83f5d19a40fe37db5c5a6c25685 | |
| ToppCell | mLN-(1)_T_cell-(17)_gd_T|mLN / shred on region, Cell_type, and subtype | 2.47e-04 | 197 | 69 | 4 | 5c781ded147db2f3804ee1f21ef0898c4f354890 | |
| ToppCell | mLN-T_cell-gd_T|mLN / Region, Cell class and subclass | 2.47e-04 | 197 | 69 | 4 | 8ef03bdbd34a874671aebfdbb7111106aa37b2a9 | |
| Disease | demyelinating disease (biomarker_via_orthology) | 1.43e-05 | 3 | 65 | 2 | DOID:3213 (biomarker_via_orthology) | |
| Disease | double outlet right ventricle (implicated_via_orthology) | 1.43e-05 | 3 | 65 | 2 | DOID:6406 (implicated_via_orthology) | |
| Disease | dextro-looped transposition of the great arteries (implicated_via_orthology) | 2.86e-05 | 4 | 65 | 2 | DOID:0060770 (implicated_via_orthology) | |
| Disease | right atrial isomerism (implicated_via_orthology) | 2.86e-05 | 4 | 65 | 2 | DOID:0060856 (implicated_via_orthology) | |
| Disease | 1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4) measurement | 7.13e-05 | 6 | 65 | 2 | EFO_0800394 | |
| Disease | X-24870 measurement | 9.96e-05 | 7 | 65 | 2 | EFO_0022143 | |
| Disease | level of Phosphatidylethanolamine (O-18:2_20:4) in blood serum | 1.33e-04 | 8 | 65 | 2 | OBA_2045151 | |
| Disease | fatty acid desaturase enzyme activity measurement | 1.33e-04 | 8 | 65 | 2 | EFO_0009791 | |
| Disease | NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO | 1.33e-04 | 8 | 65 | 2 | C3891448 | |
| Disease | level of Phosphatidylethanolamine (O-18:1_20:4) in blood serum | 2.13e-04 | 10 | 65 | 2 | OBA_2045148 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement | 2.13e-04 | 10 | 65 | 2 | EFO_0800464 | |
| Disease | Charcot-Marie-Tooth Disease | 3.11e-04 | 12 | 65 | 2 | C0007959 | |
| Disease | visceral heterotaxy (is_implicated_in) | 3.11e-04 | 12 | 65 | 2 | DOID:0050545 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 3.67e-04 | 13 | 65 | 2 | OBA_2045082 | |
| Disease | Kuhnt-Junius degeneration (is_marker_for) | 4.27e-04 | 14 | 65 | 2 | DOID:10873 (is_marker_for) | |
| Disease | – | 5.62e-04 | 16 | 65 | 2 | 609423 | |
| Disease | Susceptibility to HIV infection | 5.62e-04 | 16 | 65 | 2 | cv:C1836230 | |
| Disease | transferrin saturation measurement | 5.62e-04 | 16 | 65 | 2 | EFO_0006333 | |
| Disease | total iron binding capacity | 6.90e-04 | 78 | 65 | 3 | EFO_0006334 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 8.10e-04 | 330 | 65 | 5 | EFO_0004529, EFO_0004612 | |
| Disease | iron biomarker measurement, transferrin measurement | 8.85e-04 | 20 | 65 | 2 | EFO_0004461, EFO_0006341 | |
| Disease | serum iron measurement | 9.16e-04 | 86 | 65 | 3 | EFO_0006332 | |
| Disease | saturated fatty acids to total fatty acids percentage | 9.77e-04 | 21 | 65 | 2 | EFO_0022305 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 9.77e-04 | 21 | 65 | 2 | OBA_2045083 | |
| Disease | triacylglycerol 56:4 measurement | 1.28e-03 | 24 | 65 | 2 | EFO_0010431 | |
| Disease | D dimer measurement | 2.00e-03 | 30 | 65 | 2 | EFO_0004507 | |
| Disease | basophil percentage of leukocytes | 2.05e-03 | 243 | 65 | 4 | EFO_0007992 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLFVHYLAVVLLELR | 226 | Q9ULK5 | |
| LHSQVFLFFRVLLLR | 2216 | Q5JWR5 | |
| HVRLLFTVSLALQII | 6 | P0CG36 | |
| HLAVALFLSQLVFVI | 2506 | Q9NYQ6 | |
| LAARLAFIIVFEHLV | 881 | Q32M45 | |
| HVRLLFTVSLALQII | 6 | P0CG37 | |
| LLAIRLAFVIVFEHV | 846 | Q6IWH7 | |
| VFFLLLLAHIIALES | 131 | O95864 | |
| SVVIILFILLFFLLH | 251 | P43627 | |
| VIFVLVVALLALVLH | 181 | Q86YD5 | |
| IINLFLHLLRFLEAV | 221 | Q9HC24 | |
| LIISAIFHTIRFVLA | 621 | Q5T848 | |
| RILEIFFRHLFAQVL | 766 | Q9NRD8 | |
| RPHLELIVFVVVLIF | 26 | Q8NHA6 | |
| CVFLAFVIVLLAHRL | 706 | Q9Y5H3 | |
| HFRFLVIEAILATDL | 896 | Q14432 | |
| LFHVLVTELVFTDLL | 66 | P43116 | |
| RLFVLEILISFIDRH | 471 | Q9Y2G0 | |
| SIIVIVFFVIFIKHL | 441 | Q9UJA9 | |
| IREFFILLQVHILIQ | 1896 | Q8NG31 | |
| LVLFTVAIIGLLIFH | 486 | P49961 | |
| LILILFHTGIIVLSV | 251 | Q8NH76 | |
| LVILFSVLHIVSRVL | 1021 | O15440 | |
| QHGRLIFITVLFSII | 201 | Q9NZD1 | |
| FREIVVSLLSHQVLL | 1711 | Q5TH69 | |
| IILLTIDRYLAIVHA | 131 | P41597 | |
| LELLTIIFNFLLAVH | 2006 | Q99698 | |
| ITTLLVHIFISLVIL | 236 | Q8N4M1 | |
| VHIFISLVILGLLFV | 241 | Q8N4M1 | |
| VFFSLHAVVLTLIII | 206 | O60931 | |
| NLIRHLLLVLFLVFL | 411 | Q5T1A1 | |
| VLVLSLITFSVLRIH | 21 | Q02742 | |
| LIFHVFIIILGVANL | 541 | Q8NBW4 | |
| TLRILAILHTVISFF | 4571 | Q92736 | |
| SVVIILFILLFFLLH | 251 | P43626 | |
| HSIVILPLIYFIVVR | 296 | P43005 | |
| HFILILFFSTILLVV | 251 | Q8NGH5 | |
| RRQHKLVFFVVFLTL | 21 | Q5JRS4 | |
| HIVFSILVVVAFILG | 6 | P59543 | |
| VIFTHVRLLARAFTL | 1116 | Q9NRR4 | |
| VALEHFVLVVVRVLR | 456 | Q7Z2T5 | |
| VHLLAVVFKDFLRSI | 151 | Q8N103 | |
| LQFIFIALRLDKIIH | 151 | Q8NFB2 | |
| LQFIFIALKLDRIIH | 151 | Q9H7F4 | |
| THFIFLALLLILIVL | 1716 | Q9NTG1 | |
| EFFLLILVSVIELHR | 456 | Q7Z333 | |
| ALFVITCLVIFVLVH | 106 | O43868 | |
| LRIHLLAALITFLVY | 191 | Q8NBQ7 | |
| IEHFIHLITVVAVFL | 296 | Q13733 | |
| LLALTIIVSIVHSVF | 356 | O96005 | |
| HPRVNVVIIIFLFFV | 451 | P35523 | |
| LLATIFLDIVHISIF | 61 | Q6RW13 | |
| IFRDHIVLELFRTSL | 166 | Q96B21 | |
| FIHLVFVVLAFLTGV | 56 | Q8IY95 | |
| SILLIFIFIVLLIHF | 711 | O15455 | |
| LAIVLTQFHFLLLLA | 326 | Q9P253 | |
| AFILLQLVLITAFAH | 191 | A6NH21 | |
| RFLTLLAHLVVVITL | 11 | Q6UX40 | |
| LLLLVAFALVVVLFH | 171 | Q6P2H8 | |
| VVLFHVLLAPITALF | 181 | Q6P2H8 | |
| RHLTRLVFLDYVLIL | 301 | Q8NE00 | |
| FVVIILVIILAISLH | 261 | P13726 | |
| FILIQLVLLVDFAHS | 171 | Q13530 | |
| LVVILLSIVAVGFHI | 391 | Q9P0L9 | |
| TVFIFAFVITHVILR | 221 | Q8IZN3 | |
| FYLVILVLSAVHVIV | 476 | Q5H8A4 | |
| IELQVVHRAFLLSII | 331 | Q96MT1 | |
| VHRAFLLSIILFIVV | 336 | Q96MT1 | |
| FVHQLLVLVVFLTGL | 151 | Q9NWC5 | |
| LSIIVLHVAVLVLLF | 6 | Q01453 | |
| LHVAVLVLLFVSTIV | 11 | Q01453 | |
| GLRFTLLFVQHVLEI | 846 | O75385 | |
| IIHFAFLLSDSILLV | 286 | Q9H6D3 |